Publications by authors named "Patrick Cabri"

Claim this Profile
A
A Noninterventional, Cross-Sectional Study to Assess Patient Prostate Cancer Treatment Preferences and Experiences in Europe.
Emmanuelle Kaltenbach, Ana Maria Rodriguez-Leboeuf, Patrick Cabri, Mickael Henry-Szatkowski, Mehmet Inceer

Adv Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PRIORITI: Phase 4 study of triptorelin or active surveillance in high-risk prostate cancer.
Vsevolod Matveev, Xin Gao, Evgeny Kopyltsov, Jindan Luo, Qiang Wei, Patrick Cabri

Asia Pac J Clin Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty.
Xiao Yu, Xinran Cheng, Haiyan Wei, Xu Xu, Chunxiu Gong, Patrick Cabri

Adv Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Triptorelin 3-Month Formulation in Chinese Children with Central Precocious Puberty: A Phase 3, Open-Label, Single-Arm Study.
Xiaoping Luo, Cai Zhang, Yu Yang, Xu Xu, Xinran Cheng, Patrick Cabri

Adv Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Two Formulations of Triptorelin in Chinese Patients with Endometriosis: A Phase 3, Randomized Controlled Trial.
Xiaoyan Li, Huaifang Li, Hong Shi, Xiaomao Li, Renfeng Zhou, Patrick Cabri

Adv Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triptorelin for the relief of lower urinary tract symptoms in men with advanced prostate cancer: results of a prospective, observational, grouped-analysis study.
Thierry Gil, Fouad Aoun, Patrick Cabri, Valérie Perrot, Roland van Velthoven

Ther Adv Urol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Testosterone Suppression with Sustained-Release Triptorelin in Advanced Prostate Cancer.
Jürgen Breul, Eija Lundström, Daniela Purcea, Werner P Venetz, Patrick Cabri

Adv Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors predicting progression to castrate-resistant prostate cancer in patients with advanced prostate cancer receiving long-term androgen-deprivation therapy.
Alexandre de la Taille, Luis Martínez-Piñeiro, Patrick Cabri, Aude Houchard, Jack Schalken

BJU Int· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors and Regional Differences Associated with Endometriosis: A Multi-Country, Case-Control Study.
Charles Chapron, Jing-He Lang, Jin-Hua Leng, Yingfang Zhou, Xinmei Zhang, Patrick Cabri

Adv Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Body Image in Patients with Prostate Cancer over 2 Years of Treatment with a Gonadotropin-Releasing Hormone Analogue (Triptorelin): Results from a Belgian Non-Interventional Study.
Hans van den Driessche, Pieter Mattelaer, Peter van Oyen, Wouter Marchand, Ovadia Bar-Moshé, Patrick Cabri

Drugs Real World Outcomes· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, observational grouped analysis to evaluate the effect of triptorelin on lower urinary tract symptoms in patients with advanced prostate cancer.
Thierry Gil, Fouad Aoun, Patrick Cabri, Pascal Maisonobe, Roland van Velthoven

Ther Adv Urol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triptorelin in the Relief of Lower Urinary Tract Symptoms in Advanced Prostate Cancer Patients: The RESULT Study.
Alexandre Peltier, Fouad Aoun, Vincent De Ruyter, Patrick Cabri, Roland Van Velthoven

Prostate Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of urinary prostate cancer antigen-3 (PCA3) and TMPRSS2-ERG score changes when starting androgen-deprivation therapy with triptorelin 6-month formulation in patients with locally advanced and metastatic prostate cancer.
Luis Martínez-Piñeiro, Jack A Schalken, Patrick Cabri, Pascal Maisonobe, Alexandre de la Taille

BJU Int· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome.
Filip Van Nieuwerburgh, Dominic Stoop, Patrick Cabri, Marc Dhont, Dieter Deforce

Gynecol Endocrinol· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis